CVS Health (NYSE:CVS) Given New $72.00 Price Target at Mizuho

CVS Health (NYSE:CVS) had its price target trimmed by Mizuho from $86.00 to $72.00 in a report published on Thursday, Benzinga reports. The brokerage currently has a buy rating on the pharmacy operator’s stock.

CVS has been the topic of a number of other reports. Piper Sandler upped their target price on shares of CVS Health from $93.00 to $94.00 and gave the stock an overweight rating in a research note on Friday, March 15th. Barclays began coverage on CVS Health in a report on Wednesday, March 6th. They issued an equal weight rating and a $78.00 target price for the company. Cantor Fitzgerald lowered CVS Health from an overweight rating to a neutral rating and cut their price target for the company from $87.00 to $58.00 in a research note on Wednesday. StockNews.com cut shares of CVS Health from a buy rating to a hold rating in a report on Thursday, February 15th. Finally, UBS Group lowered shares of CVS Health from a buy rating to a neutral rating and reduced their price target for the company from $85.00 to $60.00 in a report on Thursday. Eight equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of Moderate Buy and an average price target of $80.35.

CVS Health Trading Up 1.4 %

CVS stock traded up $0.75 during midday trading on Thursday, reaching $55.90. 23,946,075 shares of the company traded hands, compared to its average volume of 12,498,538. The firm has a market capitalization of $70.18 billion, a price-to-earnings ratio of 9.82, a P/E/G ratio of 0.86 and a beta of 0.56. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.63 and a current ratio of 0.81. The business has a 50 day moving average of $72.77 and a 200-day moving average of $73.26. CVS Health has a 52-week low of $53.70 and a 52-week high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion for the quarter, compared to analysts’ expectations of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the prior year, the firm posted $2.20 earnings per share. As a group, sell-side analysts expect that CVS Health will post 7.03 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.76%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

Insider Buying and Selling at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Edward J. Ludwig acquired 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in CVS. Bryn Mawr Capital Management LLC lifted its holdings in shares of CVS Health by 74.0% in the 3rd quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock valued at $3,017,000 after buying an additional 18,385 shares during the period. Value Partners Investments Inc. boosted its holdings in CVS Health by 26.5% during the third quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock worth $69,261,000 after buying an additional 207,702 shares in the last quarter. Sonora Investment Management Group LLC grew its position in CVS Health by 1.6% during the third quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock valued at $3,525,000 after buying an additional 774 shares during the period. Checchi Capital Advisers LLC raised its position in shares of CVS Health by 2.3% in the third quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock worth $726,000 after acquiring an additional 233 shares during the period. Finally, Personal CFO Solutions LLC boosted its stake in shares of CVS Health by 2.6% during the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock worth $1,351,000 after acquiring an additional 491 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.